MoonLake Immunotherapeutics (MLTX)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
15. 13
+0.08
+0.5316%
After Hours
$
+0.18 +1.1897% 15. 31
1.27B Market Cap
- P/E Ratio
- Div Yield
662,394 Volume
-1.16 Eps
$ 15.05
Previous Close 
Want to track MLTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MoonLake Immunotherapeutics (MLTX) Statistics
Valuation metrics
Market Cap 1.27B
Enterprise value 884.52M
Trailing P/E (ttm) -3.89
Forward P/E -
PEG ratio 0.12
Price/Sales (ttm) -
Price/Book (mrq) 2.59
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.53
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 699.85K
Average volume (90 days) 1.15M
Price summary
52-Week low 5.95
52-Week high 62.75
Beta -
50-Day moving average 18.43
200-Day moving average 17.67
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.46%
Return on equity -0.83%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.27
Total debt (mrq) -
Total Debt/Equity (mrq) 0.24
Current ratio (mrq) 12.56%
Book value per share (mrq) 5.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
